Parameter | Control group | Study group (I) | Study group (II) | P-value [control group versus study group (I)] | P-value [control group versus study group (II)] | P-value [study group (I) versus study group (II)] |
---|---|---|---|---|---|---|
Mean ± SD | ||||||
Mean age (years) | 12.77 ± 4.16 | 10.73 ± 4.0 | 11.53 ± 3.49 | 0.12 | 0.30 | 0.56 |
Mean age at presentation (months) | N/A | 23.13 ± 13.36 | 15.20 ± 7.76 | N/A | N/A | 0.06 |
Sex distribution No. (%) | Â | Â | Â | Â | Â | Â |
Male | 24 (80.0) | 8 (53.3) | 9 (60.0) | 0.06 | 0.15 | 0.71a |
Female | 6 (20.0) | 7 (46.7) | 6 (40.0) | Â | Â | Â |
Diagnosis of retinoblastoma No. (%) | Â | Â | Â | Â | Â | Â |
Right | N/A | 7 (46.7) | 10 (66.7) | N/A | N/A | 0.27a |
Left | Â | 8 (53.3) | 5 (33.3) | Â | Â | Â |
Family history No. (%) | Â | Â | Â | Â | Â | Â |
Negative | N/A | 15 (100.0) | 14 (93.3) | N/A | N/A | 1.0a |
Positive | Â | 0 (0.0) | 1 (6.7) | Â | Â | Â |
Consanguinity No. (%) | Â | Â | Â | Â | Â | Â |
Negative | N/A | 13 (86.7) | 15 (100.0) | N/A | N/A | 0.48a |
Positive | Â | 2 (13.3) | 0 (0.0) | Â | Â | Â |
Mean duration of follow up (years) | N/A | 7.93 ± 3.49 | 10.38 ± 3.73 | N/A | N/A | 0.07 |
Mean BCVA (Log.MAR) | 0.11 ± 0.03 | 0.11 ± 0.05 | 0.11 ± 0.02 | 0.64 | 1.00 | 0.66 |
Mean spherical Equivalent (diopters) | 0.83 ± 0.72 | 1.28 ± 0.82 | 1.12 ± 0.60 | 0.08 | 0.16 | 0.53 |
Mean IOP (mmHg) | 11.6 ± 1.69 | 11.9 ± 1.87 | 11.53 ± 1.64 | 0.56 | 0.90 | 0.54 |
Average of mean deviation (decibels) | −1.37 ± 1.43 | −1.62 ± 1.29 | −1.41 ± 1.80 | 0.56 | 0.93 | 0.72 |
Mean of pattern standard deviation (decibels) | 1.14 ± 1.05 | 1.12 ± 1.04 | 1.14 ± 1.07 | 0.95 | 0.99 | 0.95 |